Iglay, Kristy http://orcid.org/0000-0001-7704-6646
Bennett, Dimitri
Kappelman, Michael D.
Thai, Sydney
Aldridge, Molly
Karki, Chitra
Cook, Suzanne F.
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
Article History
Received: 18 March 2021
Accepted: 22 December 2021
First Online: 28 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: Takeda Pharmaceuticals contracted with CERobs Consulting, LLC, a consulting firm with focus on real-world evidence, outcomes research, epidemiology and clinical outcome assessments, including patient reported outcomes; K. Iglay, S. Thai, M. Aldridge, and S. Cook consulted on this project through CERobs Consulting, LLC. M. Kappelman consulted for Abbvie, Janssen, Pfizer, and Takeda, is a shareholder in Johnson & Johnson, and has received research support from Pfizer, Takeda, Janssen, Abbvie, Lilly, Genentech, Boehringer Ingelheim, Bristol Myers Squibb, Celtrion, and Arenapharm. D. Bennett and C. Karki are salaried employees of Takeda Pharmaceuticals.